ZEISS Medical Technology showcased at CIIE its next-generation aspheric phakic intraocular lens (pIOL) PT LUNANA® to address myopia in China, a growing major public health challenge for the region.

Research shows: China has an estimated 600 million people with myopia; a growing number are entering adulthood with myopia: roughly two in three (67.2%) people aged 15 to 19 have myopia and 9.5% have high myopia, according to a recent systematic review.1

China’s National Medical Products Administration (NMPA) has approved ZEISS PT LUNANA, the first in the Phakic Technology (PT) family of phakic IOLs.

CIIE unveiling: ZEISS showcased the PT LUNANA pIOL at the 9th China International Import Expo (CIIE) in Shanghai, China.